Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance.

MLA

Zheng, Jie, et al. “Overall Signature of Acquired KRAS Gene Changes in Advanced Non-Small Cell Lung Cancer Patient with EGFR-TKI Resistance.” Japanese Journal of Clinical Oncology, vol. 54, no. 1, Jan. 2024, pp. 89–96. EBSCOhost, https://doi.org/10.1093/jjco/hyad123.

APA

Zheng, J., Dou, Y., Huang, D., Wang, Y., Han, R., Hu, C., Zhu, M., Lu, C., Lin, C., Wu, D., Liu, Y., Tang, H., He, T., Jiang, W., & He, Y. (2024). Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese Journal of Clinical Oncology, 54(1), 89–96. https://doi.org/10.1093/jjco/hyad123

Chicago

Zheng, Jie, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, et al. 2024. “Overall Signature of Acquired KRAS Gene Changes in Advanced Non-Small Cell Lung Cancer Patient with EGFR-TKI Resistance.” Japanese Journal of Clinical Oncology 54 (1): 89–96. doi:10.1093/jjco/hyad123.